SCHEMBL27787124

SCHEMBL27787124

CCOC(=O)CC(=O)OCc1ccc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
TACR1 P25103 1/20 0.49
CYP1A2 P05177 1/20 0.47
CYP2A6 P11509 1/20 0.47
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
RAB9A P51151 1/20 0.46
CNR2 P34972 1/20 0.45
CACNA1B Q00975 1/20 0.45
SLC1A3 P43003 1/20 0.45
SLC1A2 P43004 1/20 0.45
SLC1A1 P43005 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6910495 0.92 SLC1A3 (0.50) TACR1CYP1A2CYP2A6RAB9ASLC1A3
SCHEMBL28413975 0.86 CYP1A2 (0.52) GAATACR1CYP1A2CYP2A6RAB9A
Hydrochloric Acid SCHEMBL27504503 0.84 CYP1A2 (0.50) GAATACR1CYP1A2CYP2A6RAB9A
SCHEMBL6910501 0.84 CYP1A2 (0.51) TACR1CYP1A2SLC1A3SLC1A2SLC1A1
SCHEMBL4781267 0.84 GAA (0.51) GAACYP1A2CYP2A6CNR2
SCHEMBL3800271 0.83 GAA (0.56) GAACYP1A2CYP2A6RAB9A
SCHEMBL21652695 0.82 MGAM (0.62) GAAMGAMSIMGAM2
SCHEMBL4137536 0.81 GAA (0.49) GAACYP1A2CYP2A6RAB9ACNR2
SCHEMBL1557559 0.80 ALDH1A1 (0.61) GAAMGAMSIMGAM2RAB9A
SCHEMBL2385413 0.80 CYP4F2 (0.59) GAACYP1A2CYP2A6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101784520-B Novel malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORP 2014-07-02 CN disclosed
CN-101784520-A Novel malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORP 2010-07-21 CN disclosed